Background: Fentanyl, a synthetic opioid categorized as a narcotic analgesic, has a
number of inappropriate uses and fatal accidents involving fentanyl has also increased in the United Kingdom and Canada. 9, 10 Fentanyl is classified as a narcotic analgesic with strong effects on the central nervous system. Opioids induce psychostimulant effects other than analgesia, such as sedation, delirium, and itching. 11, 12 Although fentanyl is a useful analgesic, the use of fentanyl during surgery is associated with a higher incidence of early postoperative negative behavior such as anxiety. 13 Chronic fentanyl treatment affects physical performance of rats. 14 Such findings indicate that chronic use of fentanyl may also affect behavior, but the specific behavioral effects of chronic synthetic opioid use remain unclear. Therefore, in the present study, C57BL/6J mice chronically treated with fentanyl were assessed using a comprehensive behavioral test battery to investigate how chronic use of the synthetic opioid affects various behaviors.
| MATERIALS AND METHODS

| Animals and experimental design for comprehensive behavioral analysis
The general procedure of the experiments is illustrated in Figure 1 .
Thirty-eight naïve male C57BL/6J mice were transported from Japan SLC, Inc. (Shizuoka, Japan) to the University of Toyama at the age of 6 weeks. After their arrival, the mice were group-housed (4/cage) in a plastic cage (22.7 × 32.3 × 12.7 cm) in a room maintained at 24 ± 3°C with a 12-hour light/dark cycle (lights on at 7:00 AM) and ad libitum access to food and water. The mice were randomly assigned to either the vehicle-treated group (n = 12), the low-dose (0.03 mg/kg) fentanyl-treated group (n = 13), or the high-dose (0.3 mg/kg) fentanyl-treated group (n = 13). Fentanyl administration was started at 7 weeks of age and behaviors were assessed with a battery of behavioral tests starting at 8 weeks of age ( Figure 1 ).
| Fentanyl treatment
Mice were treated with fentanyl (0.03 or 0.3 mg/kg, ip; Janssen Pharmaceutical KK, Tokyo, Japan) in saline or saline only (1% of body weight) once a day. During behavioral testing, fentanyl was administered once a day after completing the behavioral test of the day. Fentanyl treatment was initiated when the mice were 7 weeks of age and continued for 28 days. Fentanyl treatment was then interrupted for 14 days as a withdrawal period. After that, fentanyl treatment was resumed and continued for 75 days. The fentanyl treatment and behavioral test battery schedules are described in Table 1 .
| Behavioral tests
The mice were subjected to a battery of behavioral tests in the fol- 
| Neurological screen and neuromuscular strength test
The righting, whiskers twitch, and ear twitch reflexes were evaluated. A number of physical features, including the presence of F I G U R E 1 Schematic diagram of the experimental procedures. Mice were intraperitoneally injected with fentanyl (0.03 or 0.3 mg/kg) or saline (control) once a day. As fentanyl treatment period 1, we continued fentanyl treatment for 28 days. In the first 7 days, no behavioral tests were performed as pretreatment. After the first 7 days, the behavioral test battery was performed. The fentanyl administration was interrupted for 14 days as a withdrawal period, and fentanyl treatment was resumed as treatment period 2 whiskers or bald hair patches, were also recorded. Body weight and rectal temperature were measured. Neuromuscular strength was assessed using the grip strength and wire hang tests. A grip strength meter (O'Hara & Co., Tokyo, Japan) was used to assess forelimb grip strength. Mice were lifted and held by their tail so that their forepaws grasp a wire grid. The mice were then gently pulled backward by the tail until they released the grid. The peak force applied by the forelimbs of the mouse was recorded in Newtons (N). Each mouse was tested three times, and the largest value was used for statistical analysis.
| Light/dark transition test
The light/dark transition test, developed by Crawley et al, 15 was performed as previously described. 16 The apparatus comprised a cage (21 × 42 × 25 cm) divided into two sections of equal size divided by a partition with a door (O'Hara & Co.). One chamber was brightly illuminated (390 lux), whereas the other was dark (2 lux). Mice were placed into the dark chamber and were allowed to move freely between the two chambers for 10 minutes with the door open. The distance traveled (cm), the total number of transitions between compartments, latency to first enter the light chamber (seconds), and time spent in the light chamber (seconds) were recorded automatically using the ImageLD program.
| Elevated plus maze test
The elevated plus maze test, which is widely used to assess anxietylike behavior, 17 was performed as previously described. 18 The appa- 6  Social interaction test  10  18  Table 2 7 Rotarod test 10-11 19-20 Table 2 8 Three-chamber social approach test 10-11 21-22 Table 2 9 Startle response/prepulse inhibition test 11 25 Table 2 10 -maze test  14-15  6  Table 2   17  Novel Object Location test  15-16  9-13  Table 2   18  Marble-burying test  16-17  20  Table 2 19 
| Social interaction test
The social interaction test was conducted to measure social behavior in a novel environment, as previously described. 19 Weight-matched (within 2 g) mice of the same treatment group that had been housed in different cages were placed together into an acrylic box (40 × 40 × 30 cm) and allowed to explore freely for 10 minutes. The total number of contacts, total duration of contacts (seconds), total duration of active contacts (seconds), mean duration per contact (seconds), and total distance traveled (cm) were recorded and analyzed automatically using the ImageSI program. Active contact was defined as the two mice contacted each other and one or both mice moved with a velocity of at least 10 cm/s.
| Three-chamber social approach test
The three-chamber social approach test is a well-designed method to investigate sociability and preference for social novelty in mice. 20 The apparatus comprised a rectangular, three-chambered that had had no prior contact with the subject mouse was put into a wire cage located in one of the side chambers. The location of the stranger mouse in the left vs right chamber was systematically alternated between trials. The subject mouse was placed in the central compartment and allowed to explore the entire box for 10-minutes to assess sociability (sociability test).
Next, a second stranger male mouse was placed into the wire cage in the other outside compartment that had been empty during the first 10-minute session to evaluate social preference for a new stranger (social novelty preference test). Thus, the subject mouse had a choice between the first, already-investigated, nowfamiliar mouse (stranger 1) and the novel unfamiliar mouse (stranger 2). The amount of time spent in each chamber and time spent around each cage were automatically calculated from video images using the ImageCSI program.
| Rota rod test
Motor coordination and balance were tested with the rotarod test. The rotarod test, using an accelerating rotarod (UGO Basile Accelerating Rotarod, Varese, Italy), was performed by placing the mice on a rotating drum (3 cm diameter), and measuring the time each animal was able to maintain its balance on the drum. The speed of the rotarod accelerated from 4 to 40 rpm over a 5-minute period.
| Hot plate test
The hot plate test was used to evaluate sensitivity to a painful stim- 
| Porsolt forced swim test
The Porsolt forced swim test 22 155. 
| Y-maze test
| Contextual and cued fear conditioning test
The fear conditioning test was conducted using an automated video-analysis system as previously described. 24 Mice were placed automatically using the ImageFZ program in the same manner as previously described. 24 Due to technical problems with the videoanalysis system, we failed to obtain cued test data for one mouse in the high-dose group 7 days after the conditioning session and therefore excluded the data for this mouse from the statistical analysis. 
| Open field test
| Novel object location test
Each mouse was placed in the corner of the open field apparatus (40 × 40 × 30 cm). The center of the apparatus was illuminated at 100 lux. On days 1-3, the mice were allowed to explore the chamber for 10 minutes as habituation. On day 4, two identical objects were placed centrally 20 cm apart in the chamber and the mice were allowed to explore the chamber for 15 minutes as a training session.
On day 5, one of the objects was placed in the same location as on 
| Marble-burying test
The marble-burying test assesses anxiety-like/compulsive behavior based on spontaneous digging behavior. 25 Twenty marbles were dis- 
| Data analysis in behavioral tests
Behavioral data were obtained automatically by applications (ImageLD, 16 ImageEP, 18 ImageSI, 19 ImageCSI, 26 ImagePS, 19 ImageYM, 23 and 
| Statistical analysis
Statistical analyses were performed using StatView (SAS Institute, Cary, NC, USA). Data were analyzed using one-way or two-way ANOVA followed by Fisher's LSD test, two-way repeated ANOVA, or paired t-test where appropriate. Values in graphs are presented as mean ± SEM. For multiple comparisons in the behavioral test battery, we defined study-wide significance as statistical significance after controlling for the false discovery rate (FDR). 27, 28 Nominal significance was defined as a statistically significant difference in an index (P < 0.05) that did not survive FDR correction. The results of the statistical analysis are described in Table 2 .
3 | RESULTS
| Effects of chronic fentanyl administration on the general health of the mice
Body weight did not differ significantly among the three groups of mice in either the treatment or the withdrawal periods (Figure 2B , The P values indicate a treatment effect in one-way ANOVA or two-way repeated measures ANOVA. In the elevated plus maze test, the asterisk indicates a nominally significant difference for comparisons between treatment groups (P < 0.05). (F-G). In the Porsolt forced swim test, the asterisk and number sign indicate a nominally significant difference between the high-dose group and low-dose group and between the low-dose group and control group (P < 0.05) E). In the withdrawal period, the low-dose group tended to have a lower body temperature (withdrawal period: treatment effect, P = 0.0712; controls vs high-dose treatments, P = 0.4153, controls vs low-dose treatments, P = 0.1402, low-dose treatments vs highdose treatments, P = 0.0246; Figure 2F ). Neuromuscular strength was measured by grip strength. Grip strength was significantly lower in the high-dose group than in the other groups in both the treatment and withdrawal periods (Treatment period 1: treatment effect, P = 0.0132; controls vs high-dose treatments, P = 0.015, low-dose treatments vs high-dose treatments, P = 0.0077; withdrawal period: treatment effect, P = 0.0074; controls vs high-dose treatments, P = 0.0079, low-dose treatments vs high-dose treatments, P = 0.0047; Figure 2D ,G).
| Mice in the high-dose fentanyl group exhibited reduced anxiety-like behavior
In the open field test, we measured the total distance traveled, verti- (Table 2 ).
In the Porsolt forced swim test, mice in the low-dose group exhibited an immobile posture for a significantly shorter time than the other groups (treatment effect, P = 0.0148; controls vs low-dose group, P = 0.0072, low-dose group vs high-dose group, P = 0.0104; Figure 4H ). The decreased immobility of the low-dose group implies that fentanyl has an anti-depressive effect.
| Mice in the high-dose fentanyl group exhibited increased anxiety-like behavior during the withdrawal period
To investigate the effect of withdrawal from chronic fentanyl treatment, we performed a general health and neurologic screening, as well as light/dark transition, elevated plus maze, and hot plate tests during the withdrawal period. In the light/dark transition test, mice in the high-dose group tended to remain in the light chamber for a shorter period of time than the other groups ( Figure 5C ). Mice in the high-dose group spent significantly less time in the light chamber in the first half of the testing period (A)
F I G U R E 5 Mice in the high-dose group exhibited higher anxiety-like behavior in the withdrawal period. We performed the light and dark transition test during the withdrawal period (A). Distance traveled (B), time spent in the light chamber (C), total number of light/dark transitions (D), and latency to enter the light compartment (E) are shown. There was no significant difference among groups (B-E). Mice in the high-dose group remained in the light chamber for a significantly shorter time during the first 0-5 minutes (F). Data are presented as means ± SEM for the indicated numbers of animals. The P values indicate the treatment effect in one-way ANOVA or two-way repeated measures ANOVA. The asterisk indicates a nominally significant difference for comparisons between treatment groups (P < 0.05) (treatment effect, P = 0.0388; controls vs high-dose group, P = 0.0472, low-dose group vs high-dose group P = 0.0166; Figure 5F ). In the elevated plus maze test during the withdrawal period, there were no significant differences between groups (Table 2) , although in the fentanyl treatment period, the high-dose group showed decreased anxiety compared with controls (Figure 4F) . Thus, during the withdrawal period, fentanyl interruption may increase anxiety-like behavior in mice administered high-dose fentanyl.
| Mice treated chronically with fentanyl exhibit abnormal pain sensitivity
We performed the hot plate test to assess pain sensitivity in mice with chronic fentanyl treatment. The latency to the first hind paw response on the hot plate (preheated to 55°C) was significantly longer in both the low-and high-dose fentanyl treatment groups than in controls (treatment effect, P = 0.0294; controls vs lowdose group, P = 0.0364, controls vs high-dose group, P = 0.0126; Figure 6B ), suggesting that fentanyl inhibited sensitivity to painful stimuli. The hot plate test was also performed during the withdrawal period ( Figure 6A ). The latency to the first hind paw response was not significantly different among the three groups ( Figure 6C ). After the withdrawal period, we resumed fentanyl treatment and performed the contextual and cued fear conditioning test to assess fear memory ( Figure 6A ). The freezing ratio during the context and cued tests was not significantly different among the groups (Figure 6D-H) . The distance traveled by the high-dose group after the third footshock, however, was greater than that of the controls (treatment effect, P = 0.0395; treatment × time, P = 0.0029; controls vs low-dose group, P = 0.3075, controls vs high-dose group, P = 0.019; Figure 6I ). This finding controls vs low-dose group, P = 0.8839, controls vs high-dose group P = 0.0222; stereotypic counts: treatment effect, P = 0.0641; treatment × time, P = 0.1115; controls vs low-dose group, P = 0.9235, controls vs high-dose group P = 0.0157; Figure 8F ,I). These results suggest chronical fentanyl treatment reduces the sensitivity to cocaine.
| Other behaviors
Locomotor activity tended to be lower in the high- There were also no significant differences among groups in the results of the social interaction, social approach, novel object location, and prepulse inhibition tests (Table 2 ).
| DISCUSSION
In the present study, we performed a comprehensive behavioral test battery to assess the effect of chronic fentanyl treatment on mouse behaviors. Our findings revealed lower anxiety-like behavior Chronic treatment with high-dose fentanyl reduced anxiety-like behavior in adult C57BL/6J mice. As previously reported, activation of the opioid system has anxiolytic-like effects. 29 Fentanyl treatment positively affects the mental component score of the Short Form 12 Health Survey in cancer patients. 30 Our results are consistent with these reports. Conversely, during the In the hot plate test, mice treated with fentanyl had a longer latency to the first hind paw response. In contrast, during the withdrawal periods, there was no significant difference among the three groups in the hot plate test. These findings suggest that fentanyl attenuated pain sensitivity in mice and are consistent with previous findings in animal pain models. 32 In the fear conditioning test, however, the increased locomotor activity after electric shocks in the high-dose group was greater than that in the control group. This finding implies that fentanyl induces hyperalgesia in mice. Chronic use of opioids sometime induces hyperalgesia. 33 Our results suggest that this inverted pain sensitivity of fentanyl treatment may be triggered by long-term treatment or interruption of fentanyl treatment.
Addiction to fentanyl and fatal fentanyl overdoses are emerging social problems in the United States. 8 Recent news that a celebrity died of a fentanyl overdose attracted great attention. 34 Furthermore, fentanyl co-administered with other addictive drugs such as cocaine and heroin is intended to enhance the strong feelings of pleasure. 35, 36 The resulting mixtures cause high mortality rates. 35 In our results, high-dose fentanyl treatment attenuated cocaine-induced hyper locomotor activity and stereotypic behavior. Chronic fentanyl treatment has inhibitory effects on cocaine sensitivity. Opioids affect the central nervous system by activating mu, kappa, and delta opioid receptors. [37] [38] [39] Natural and synthetic opioids activate these receptors and stimulate analgesia, reward, and/or pleasure. 38 A positron emission tomography study revealed that mu opioid receptor binding with [ 11 C] carfentanil is increased in cocaine-abusing patients. 40, 41 To unify these previous reports, we expected that cocaine and fentanyl would have synergistic effects. Contrary to our expectations, mice treated with high-dose fentanyl had lower sensitivity to cocaine than the control group. Negus's group, however, reported substantial individual differences in the effects of mu agonists in cocaine discrimination tasks in monkeys. 42 Cocaine addiction patients are less responsive than healthy controls to mu opioid receptor agonists. 43 Characteristic opioid effects are dependent on receptor selectivity and affinity. 44, 45 Fentanyl is a strong mu opioid receptor agonist, but it also has the ability to bind two other receptors, kappa and delta receptors. 46 Kappa opioid receptor agonists are a candidate treatment for cocaine dependence and inhibit cocaine reward behavior in mice. 47, 48 Chronic fentanyl treatment may activate kappa opioid receptors, thereby inhibiting the response to cocaine. Further investigation is needed to reveal the fentanyl-induced inhibitory effects on the response to cocaine.
Although the mechanisms underlying the behavioral responses induced by chronic fentanyl treatment require further investigation, the distinctive behavioral alterations of mice in this study provide basic data to investigate the side effects of other opioids and will facilitate further in vivo studies of the effects of novel synthetic opioids. 
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